Global Alopecia Drugs Market 2016-2020

Global Alopecia Drugs Market 2016-2020

  • November 2016 •
  • 76 pages •
  • Report ID: 4391073 •
  • Format: PDF
About Alopecia Drugs

Alopecia is a loss of hair and can occur at any age across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. Few of the primary ones are a sedentary lifestyle, unhealthy diets, and side effects of certain medical treatments. Moreover, hormonal imbalance and aging increase the probability of developing a chronic disease like cancer, arthritis, depression, and hypertension, which would also lead to hair loss, especially among middle-to-late-aged people.

Technavio’s analysts forecast the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.


Covered in this report

The report covers the present scenario and the growth prospects of the global alopecia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of alopecia drugs.


The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

Technavio's report, Global Alopecia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

- GlaxoSmithKline
- Johnson & Johnson
- Merck


Other prominent vendors

- Aclaris Therapeutics
- Actelion Pharmaceuticals
- Almirall
- AndroScience
- Anterios
- Aqua Pharmaceuticals
- Astellas Pharma
- Bayer HealthCare
- BERG Health
- BiologicsMD
- BioPharmX
- Celtaxsys
- Cipher Pharmaceuticals
- Concert Pharmaceuticals
- Cosmo Pharmaceuticals
- Dermira
- Elorac
- F. Hoffmann-La Roche
- Foamix
- Guthy-Renker
- Helix BioMedix
- Hygeia Therapeutics
- Hyundai Pharm
- Incyte
- Kasiak Research
- Kythera Biopharmaceuticals
- Mylan
- NovaLead Pharma
- Novan
- Oculus Innovative Sciences
- Paratek Pharmaceuticals
- Photocure
- Polichem
- Promius Pharma
- Ranbaxy Laboratories
- Reckitt Benckiser
- Regience
- Samumed
- RepliCel
- Skinvisible Pharmaceuticals
- Teva Pharmaceutical
- Versapharm
- XBiotech


Market driver

- Popularity of off-label and OTC drugs
- For a full, detailed list, view our report


Market challenge

- Limited availability of approved drugs
- For a full, detailed list, view our report


Market trend

- Emergence of laser technology and platelet-rich plasma (PRP) therapy
- For a full, detailed list, view our report


Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.